About us
Our performance highlights
The infographics below present some of our performance highlights for the financial year 1 August 2024 to 31 July 2025.
Our ‘Year in numbers’ summarises our performance across our technology transfer, consultancy and venture activities, and includes some cumulative data alongside a set of ‘Longer term’ highlights.
Year in numbers
1,129
total number of ideas disclosed to Cambridge Enterprise
20
e 20 new companies formed
874
121 commercial and 753 research licences signed
372
patent applications filed
£3.2m
invested in patents and proof of concept
2,771
researchers supported
528
consultancy agreements signed
375
consultancy clients supported
£4.3m
invested in 32 spinouts
196
current companies in cash and equity portfolio as at 31/7/25
£94.2m
current value of cash and equity portfolio as at 31/7/25
£402m
total amount raised by cash and equity portfolio companies*
3.07x
multiple across realised cash investments
Longer term
£>4m
Technology Investment Fund committed into >40 projects
£4.9bn
follow-on funding raised by cash and equity portfolio companies
Impact
notable spinouts: BlueGnome, Centessa Pharmaceuticals, Solexa, VocalIQ
*across all holdings in 2024/25
